Coeptis Therapeutics Holdings Inc

NASDAQ:COEP  
0.94
0.00 (-0.43%)
5:59:41 PM EDT: $0.98 +0.05 (+5.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)23.43M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.5 Million
Adjusted EPS-$0.01
See more estimates
10-Day MA$0.98
50-Day MA$1.10
200-Day MA$1.45
See more pivots

Coeptis Therapeutics Holdings Inc Stock, NASDAQ:COEP

105 Bradford Road, Suite 420, Wexford, Pennsylvania 15090
United States of America
Phone: +1.724.934.6467
Number of Employees: 5
http://www.coeptistx.com

Description

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company. It develops innovative cell therapy platforms for cancer that have the potential to disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.